Iktos

Iktos, a company specialized in Artificial Intelligence for new drug design, announced that Kissei Pharmaceutical Co., Ltd. (“Kissei”), a Japanese…

Iktos, a company specialized in Artificial Intelligence for new drug design and Curreio, a Japanese company specializing in structural analysis of…

Iktos, a company specializing in artificial intelligence for new drug discovery, announces the closing of a € 15.5 Million Series A financing co-led…

Iktos, a leader in Artificial Intelligence for new drug design, announced a collaboration with Medicines for Malaria Venture (MMV), a leading product…

Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a collaboration with Galapagos, a leading global…

Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design Collaboration leverages…

Iktos, a company specialized in Artificial Intelligence (AI) for new drug design and Sygnature Discovery, a leading integrated drug discovery CRO…

Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Teijin Pharma Limited, the core company of the Teijin Group’s…